Diabetes: Secondary Complications, Regulation and Innovation

-

Join your peers at the only conference dedicated to the leading causes of mortality and morbidity in diabetes, this autumn, in London. Our distinguished faculty unite the fields of pharmacology, nanotechnology and clinical medicine to target atherosclerosis, endothelial inflammation and end-stage renal disease.

SMi's unique program brings together the latest research from those at the forefront of attenuating the complications arising from hyperglycaemia, dyslipidaemia, and angiopathy.

“This conference is an excellent one stop shop to up-skill on current issues in diabetes therapy. I’m happy to chair what will no doubt be a very stimulating session.” – Phil Ambery, Medical Director, GlaxoSmithKline

Key Reasons to Attend:
• Receive clinical updates on novel GLP1 receptor agonists, and SLGT2 and DPP-4 inhibitors
• Utilise biomarkers and imaging for the development of novel therapies for diabetes
• Discuss new therapeutic targets to reduce hypertension, hyperkalaemia and endothelial inflammation in diabetes
• Remain abreast of new EU and FDA guidelines on clinical trials on risk-benefit assessment
• Capitalise on the effects of targeting RAAS, CCN2 and CCN3 inhibitors
• Review clinical results from the DEMAND study

Key Speakers Include:
• James F. List, Vice President and Full Development Lead, Dapagliflozin, Bristol-Myers Squibb
• John Wilding, Professor of Medicine & Honorary Consultant Physician, Head of Department of Obesity and Endocrinology, University of Liverpool Hospital
• Martin Siman, Director, Design and Interpretation Centre of Excellence, AstraZeneca
• Philip Ambery, Director, Clinical Development, GlaxoSmithKline
• Sandra Souza, Team Lead, Molecular Biomarkers, PPDM , Merck Sharp & Dohme

Diabetes: Secondary Complications, Regulation and Innovation, promises to be a unique platform for networking, problem solving and learning from timely case studies. This really is a unique event not to be missed.

Click here to find out more and/or book your place.


Location:
Marriott Hotel, Regents Park
UK
UK


Organizer: SMi Group Ltd

1 Oct 2013



All Upcoming Events
1 2 Next 
ESCMID European Society of Clinical Microbiology and Infectious Diseases25 Apr 2015
Pre-Filled Syringes America 201527 Apr 2015
2nd Annual Food, Nutrition and Agriculture Genomics Congress29 Apr 2015
Lyophilisation & Freeze Drying USA29 Apr 2015
American Society for Cytotechnology1 May 2015
PEGS4 May 2015
Nordic Chemical Biology Meeting 20155 May 2015
ISBER5 May 2015
FT US Healthcare and Life Sciences Conference6 May 2015
Pharmacovigilance, Drug Safety and Risk Management11 May 2015
Formulation & Drug Delivery Congress18 May 2015
5th Annual European Food Manufacturing & Safety Summit 201518 May 2015
Cutting-Edge Technologies for Target Validation Conference 201518 May 2015
15th Annual Pain Therapeutics Conference18 May 2015
ADC Summit 201518 May 2015
Clinical Trial Logistics20 May 2015
World Stem Cells & Regenerative Medicine Congress20 May 2015
World Cord Blood Congress20 May 2015
World Biosimilar Congress USA 201527 May 2015
Cell Culture World Congress USA 201527 May 2015
Americas Antibody Congress 201527 May 2015
The American Association of Immunologists30 May 2015
63rd ASMS Conference on Mass Spectrometry and Allied Topics31 May 2015
Biomarkers World Europe2 Jun 2015
European Association of Allergology and Clinical Immunology – EEACI Congress6 Jun 2015
AAPS8 Jun 2015
ESHRE (European Society of Human Reproduction and Embryology)14 Jun 2015
Next Generation Sequencing Data Congress15 Jun 2015
ACHEMA 201515 Jun 2015
BIO International Convention15 Jun 2015

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement